607 related articles for article (PubMed ID: 26514451)
21. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma.
Iwadate Y; Matsutani T; Hirono S; Shinozaki N; Saeki N
J Neurooncol; 2016 Aug; 129(1):101-7. PubMed ID: 27193555
[TBL] [Abstract][Full Text] [Related]
22. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
23. Snail depletes the tumorigenic potential of glioblastoma.
Savary K; Caglayan D; Caja L; Tzavlaki K; Bin Nayeem S; Bergström T; Jiang Y; Uhrbom L; Forsberg-Nilsson K; Westermark B; Heldin CH; Ferletta M; Moustakas A
Oncogene; 2013 Nov; 32(47):5409-20. PubMed ID: 23524585
[TBL] [Abstract][Full Text] [Related]
24. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells.
Ouanouki A; Lamy S; Annabi B
Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384
[TBL] [Abstract][Full Text] [Related]
25. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
26. A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.
Tate CM; Pallini R; Ricci-Vitiani L; Dowless M; Shiyanova T; D'Alessandris GQ; Morgante L; Giannetti S; Larocca LM; di Martino S; Rowlinson SW; De Maria R; Stancato L
Cell Death Differ; 2012 Oct; 19(10):1644-54. PubMed ID: 22539003
[TBL] [Abstract][Full Text] [Related]
27. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
[TBL] [Abstract][Full Text] [Related]
28. Novel Acetamide-Based HO-1 Inhibitor Counteracts Glioblastoma Progression by Interfering with the Hypoxic-Angiogenic Pathway.
D'Amico AG; Maugeri G; Vanella L; Consoli V; Sorrenti V; Bruno F; Federico C; Fallica AN; Pittalà V; D'Agata V
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791428
[TBL] [Abstract][Full Text] [Related]
29. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311
[TBL] [Abstract][Full Text] [Related]
31. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
[TBL] [Abstract][Full Text] [Related]
32. Snail regulates BMP and TGFβ pathways to control the differentiation status of glioma-initiating cells.
Caja L; Tzavlaki K; Dadras MS; Tan EJ; Hatem G; Maturi NP; Morén A; Wik L; Watanabe Y; Savary K; Kamali-Moghaddan M; Uhrbom L; Heldin CH; Moustakas A
Oncogene; 2018 May; 37(19):2515-2531. PubMed ID: 29449696
[TBL] [Abstract][Full Text] [Related]
33. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.
Wang Z; Zhang S; Siu TL; Huang S
Curr Pharm Des; 2015; 21(10):1268-71. PubMed ID: 25506897
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor β and bone morphogenetic protein actions in brain tumors.
Caja L; Bellomo C; Moustakas A
FEBS Lett; 2015 Jun; 589(14):1588-97. PubMed ID: 25957771
[TBL] [Abstract][Full Text] [Related]
36. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
37. PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling.
Uthanaphun T; Manochantr S; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38687607
[TBL] [Abstract][Full Text] [Related]
38. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
39. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules.
He B; Jabouille A; Steri V; Johansson-Percival A; Michael IP; Kotamraju VR; Junckerstorff R; Nowak AK; Hamzah J; Lee G; Bergers G; Ganss R
J Pathol; 2018 Jun; 245(2):209-221. PubMed ID: 29603739
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling.
Lan T; Wang H; Zhang Z; Zhang M; Qu Y; Zhao Z; Fan X; Zhan Q; Song Y; Yu C
Exp Cell Res; 2017 Aug; 357(1):51-58. PubMed ID: 28442265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
